Adage Capital Partners Gp, L.L.C. Kal Vista Pharmaceuticals, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $51 Billion
- Q1 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 2,575,000 shares of KALV stock, worth $30.1 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
2,575,000
Previous 705,000
265.25%
Holding current value
$30.1 Million
Previous $8.64 Million
253.62%
% of portfolio
0.06%
Previous 0.02%
Shares
18 transactions
Others Institutions Holding KALV
# of Institutions
131Shares Held
46.5MCall Options Held
113KPut Options Held
72K-
Vr Adviser, LLC New York, NY6.25MShares$72.9 Million6.36% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.19MShares$48.9 Million2.13% of portfolio
-
Tang Capital Management LLC San Diego, CA4.13MShares$48.1 Million5.96% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.69MShares$43 Million2.3% of portfolio
-
Black Rock Inc. New York, NY2.43MShares$28.4 Million0.0% of portfolio
About KalVista Pharmaceuticals, Inc.
- Ticker KALV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,602,000
- Market Cap $287M
- Description
- KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...